Home › Funds › Privium Fund Management B.V. › RNAC

Privium Fund Management B.V. position in RNAC

CARTESIAN THERAPEUTICS · Health Care

Privium Fund Management B.V. reported holding 155,000 shares of RNAC (CARTESIAN THERAPEUTICS) in its Q3 2026 13F filing — a position valued at US$1.1M, representing 0.22% of its reported portfolio and ranking #39 among its reported holdings. Privium Fund Management B.V. has disclosed RNAC holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)155.00K sh
Reported value held$1.12M
Portfolio Weight0.22%
First reportedQ4 2025
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Privium Fund Management B.V.'s RNAC position evolved

Privium Fund Management B.V. first disclosed a stake in RNAC in Q4 2025 at 172,500 shares (US$1.2M). The position peaked in Q2 2026 at 151,675 shares, worth US$1.6M. Across 4 filings, Privium Fund Management B.V. increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 155,000 shares valued at US$1.1M — an increase of 3,325 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2025 172.50K $1.24M New
Q1 2026 179.11K $1.10M Add
Q2 2026 151.68K $1.58M Reduce
Q3 2026 155.00K $1.12M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RNAC and 13F data

RNAC (CARTESIAN THERAPEUTICS) is a Health Care company. 35 other funds we track also report a position in RNAC. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RNAC

No other tracked fund reports a position in RNAC.

All RNAC fund holders →

FAQ

How long has Privium Fund Management B.V. held RNAC?

Privium Fund Management B.V. has disclosed RNAC holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Privium Fund Management B.V.'s current position in RNAC?

As of Q3 2026, Privium Fund Management B.V. holds 155.00K shares of RNAC (CARTESIAN THERAPEUTICS), valued at $1.12M, representing 0.22% of its reported portfolio and ranking #39.

Has Privium Fund Management B.V. been buying or selling RNAC?

In the latest 13F filing (Q3 2026), Privium Fund Management B.V. increased its position in RNAC. The position peaked in Q2 2026 at 151.68K shares.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.